- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- homo-16-mer
- Ligands
- 32 x FE2: FE (II) ION(Non-covalent)
- 56 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 5 residues within 4Å:- Chain A: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.4: 2 residues within 4Å:- Chain A: S.144, N.148
Ligand excluded by PLIPSO4.5: 3 residues within 4Å:- Chain A: P.161, S.162, S.163
Ligand excluded by PLIPSO4.7: 6 residues within 4Å:- Chain A: T.76, Q.77
- Chain B: K.78, G.80, K.81, V.82
Ligand excluded by PLIPSO4.10: 4 residues within 4Å:- Chain B: K.50, S.163, T.164
- Ligands: FEC.6
Ligand excluded by PLIPSO4.11: 2 residues within 4Å:- Chain B: S.144, N.148
Ligand excluded by PLIPSO4.12: 3 residues within 4Å:- Chain B: K.114
- Chain G: K.114
- Chain N: K.114
Ligand excluded by PLIPSO4.13: 3 residues within 4Å:- Chain B: P.161, S.162, S.163
Ligand excluded by PLIPSO4.16: 5 residues within 4Å:- Chain C: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.17: 2 residues within 4Å:- Chain C: S.144, N.148
Ligand excluded by PLIPSO4.18: 1 residues within 4Å:- Chain C: K.114
Ligand excluded by PLIPSO4.19: 3 residues within 4Å:- Chain C: P.161, S.162, S.163
Ligand excluded by PLIPSO4.23: 6 residues within 4Å:- Chain D: K.50, S.162, S.163, T.164, G.165
- Ligands: FEC.20
Ligand excluded by PLIPSO4.24: 3 residues within 4Å:- Chain D: S.144, K.147, N.148
Ligand excluded by PLIPSO4.25: 3 residues within 4Å:- Chain D: P.161, S.162, S.163
Ligand excluded by PLIPSO4.26: 1 residues within 4Å:- Chain E: K.114
Ligand excluded by PLIPSO4.29: 3 residues within 4Å:- Chain E: S.144, K.147, N.148
Ligand excluded by PLIPSO4.30: 3 residues within 4Å:- Chain E: P.161, S.162, S.163
Ligand excluded by PLIPSO4.34: 5 residues within 4Å:- Chain F: K.50, S.163, T.164, G.165
- Ligands: FEC.31
Ligand excluded by PLIPSO4.35: 2 residues within 4Å:- Chain F: N.4, R.5
Ligand excluded by PLIPSO4.36: 3 residues within 4Å:- Chain F: P.161, S.162, S.163
Ligand excluded by PLIPSO4.39: 4 residues within 4Å:- Chain G: K.50, S.162, S.163, T.164
Ligand excluded by PLIPSO4.40: 2 residues within 4Å:- Chain G: S.144, N.148
Ligand excluded by PLIPSO4.41: 3 residues within 4Å:- Chain G: P.161, S.162, S.163
Ligand excluded by PLIPSO4.45: 6 residues within 4Å:- Chain H: K.50, S.162, S.163, T.164, G.165
- Ligands: FEC.42
Ligand excluded by PLIPSO4.46: 2 residues within 4Å:- Chain H: N.4, R.5
Ligand excluded by PLIPSO4.47: 2 residues within 4Å:- Chain H: S.144, N.148
Ligand excluded by PLIPSO4.48: 3 residues within 4Å:- Chain H: P.161, S.162, S.163
Ligand excluded by PLIPSO4.49: 2 residues within 4Å:- Chain H: K.114
- Chain I: K.114
Ligand excluded by PLIPSO4.52: 3 residues within 4Å:- Chain I: K.50, T.164, G.165
Ligand excluded by PLIPSO4.53: 2 residues within 4Å:- Chain I: N.4, R.5
Ligand excluded by PLIPSO4.54: 3 residues within 4Å:- Chain I: S.144, K.147, N.148
Ligand excluded by PLIPSO4.55: 3 residues within 4Å:- Chain I: P.161, S.162, S.163
Ligand excluded by PLIPSO4.59: 5 residues within 4Å:- Chain J: K.50, S.163, T.164, G.165
- Ligands: FEC.56
Ligand excluded by PLIPSO4.60: 1 residues within 4Å:- Chain J: K.114
Ligand excluded by PLIPSO4.61: 3 residues within 4Å:- Chain J: P.161, S.162, S.163
Ligand excluded by PLIPSO4.64: 4 residues within 4Å:- Chain K: K.50, S.163, T.164, G.165
Ligand excluded by PLIPSO4.65: 3 residues within 4Å:- Chain K: S.144, K.147, N.148
Ligand excluded by PLIPSO4.66: 3 residues within 4Å:- Chain K: P.161, S.162, S.163
Ligand excluded by PLIPSO4.69: 6 residues within 4Å:- Chain L: K.50, S.162, S.163, T.164, G.165
- Ligands: FEC.73
Ligand excluded by PLIPSO4.70: 2 residues within 4Å:- Chain L: N.4, R.5
Ligand excluded by PLIPSO4.71: 1 residues within 4Å:- Chain L: K.114
Ligand excluded by PLIPSO4.72: 3 residues within 4Å:- Chain L: P.161, S.162, S.163
Ligand excluded by PLIPSO4.76: 5 residues within 4Å:- Chain M: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.77: 3 residues within 4Å:- Chain M: N.4, R.5, E.6
Ligand excluded by PLIPSO4.78: 3 residues within 4Å:- Chain M: S.144, K.147, N.148
Ligand excluded by PLIPSO4.79: 3 residues within 4Å:- Chain M: P.161, S.162, S.163
Ligand excluded by PLIPSO4.83: 5 residues within 4Å:- Chain N: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.84: 2 residues within 4Å:- Chain N: S.144, N.148
Ligand excluded by PLIPSO4.85: 3 residues within 4Å:- Chain N: P.161, S.162, S.163
Ligand excluded by PLIPSO4.88: 2 residues within 4Å:- Chain O: S.144, N.148
Ligand excluded by PLIPSO4.89: 3 residues within 4Å:- Chain O: P.161, S.162, S.163
Ligand excluded by PLIPSO4.90: 3 residues within 4Å:- Chain F: K.114
- Chain K: K.114
- Chain P: K.114
Ligand excluded by PLIPSO4.93: 5 residues within 4Å:- Chain P: K.50, S.163, T.164, G.165
- Ligands: FEC.96
Ligand excluded by PLIPSO4.94: 3 residues within 4Å:- Chain P: S.144, K.147, N.148
Ligand excluded by PLIPSO4.95: 3 residues within 4Å:- Chain P: P.161, S.162, S.163
Ligand excluded by PLIP- 8 x FEC: 1,3,5,8-TETRAMETHYL-PORPHINE-2,4,6,7-TETRAPROPIONIC ACID FERROUS COMPLEX(Non-covalent)
FEC.6: 20 residues within 4Å:- Chain A: R.20, L.24, H.28, M.31, Y.35, K.50, M.57, E.61, S.168
- Chain B: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168
- Ligands: SO4.10
17 PLIP interactions:7 interactions with chain A, 10 interactions with chain B,- Hydrophobic interactions: A:L.24, A:E.61, B:I.27, B:M.31, B:E.61
- Hydrogen bonds: A:Y.35, A:Y.35, B:Y.35, B:S.168, B:S.168
- Water bridges: A:R.20, B:R.20, B:K.169
- Salt bridges: A:R.20, A:H.28, B:R.20, B:K.50
FEC.20: 22 residues within 4Å:- Chain C: R.20, L.24, I.27, H.28, M.31, Y.35, K.50, M.57, R.58, E.61
- Chain D: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168, K.169
- Ligands: SO4.23
17 PLIP interactions:7 interactions with chain D, 10 interactions with chain C,- Hydrophobic interactions: D:I.27, D:M.31, D:E.61, C:L.24, C:I.27, C:M.31, C:R.58, C:E.61
- Hydrogen bonds: D:S.168, D:K.169, C:Y.35, C:R.58
- Salt bridges: D:R.20, D:K.50, C:R.20, C:H.28
- Water bridges: C:R.20
FEC.31: 23 residues within 4Å:- Chain E: R.20, L.24, H.28, M.31, Y.35, K.50, I.54, M.57, E.61, S.168, K.169
- Chain F: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168, K.169
- Ligands: SO4.34
17 PLIP interactions:8 interactions with chain E, 9 interactions with chain F,- Hydrophobic interactions: E:L.24, E:M.31, E:I.54, E:E.61, F:I.27, F:E.61
- Hydrogen bonds: E:Y.35, E:K.169, F:S.168, F:S.168, F:K.169
- Salt bridges: E:R.20, E:H.28, F:R.20, F:H.28, F:K.50
- Water bridges: F:T.164
FEC.42: 21 residues within 4Å:- Chain G: R.20, L.24, I.27, H.28, M.31, Y.35, K.50, M.57, E.61
- Chain H: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168, K.169
- Ligands: SO4.45
17 PLIP interactions:9 interactions with chain G, 8 interactions with chain H,- Hydrophobic interactions: G:L.24, G:I.27, G:M.31, G:M.57, G:E.61, H:E.61
- Hydrogen bonds: G:Y.35, G:Y.35, H:Y.35, H:S.168, H:S.168, H:K.169
- Salt bridges: G:R.20, G:H.28, H:R.20, H:K.50
- Water bridges: H:R.20
FEC.56: 20 residues within 4Å:- Chain I: R.20, L.24, I.27, H.28, M.31, Y.35, K.50, M.57, E.61
- Chain J: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168
- Ligands: SO4.59
15 PLIP interactions:6 interactions with chain J, 9 interactions with chain I,- Hydrophobic interactions: J:I.27, J:E.61, I:L.24, I:I.27, I:I.27, I:M.31, I:E.61
- Hydrogen bonds: J:S.168, J:S.168, I:Y.35, I:Y.35
- Salt bridges: J:R.20, J:K.50, I:R.20, I:H.28
FEC.73: 20 residues within 4Å:- Chain K: R.20, I.27, H.28, M.31, Y.35, K.50, I.54, M.57, E.61
- Chain L: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, S.168, K.169
- Ligands: SO4.69
18 PLIP interactions:8 interactions with chain K, 10 interactions with chain L,- Hydrophobic interactions: K:I.27, K:I.27, K:I.54, K:E.61, L:I.27, L:M.31, L:E.61
- Hydrogen bonds: K:Y.35, L:Y.35, L:S.168, L:S.168, L:K.169
- Water bridges: K:R.20, L:R.20
- Salt bridges: K:R.20, K:H.28, L:R.20, L:K.50
FEC.80: 20 residues within 4Å:- Chain M: R.20, L.24, I.27, H.28, M.31, Y.35, K.50, M.57, R.58, E.61
- Chain N: R.20, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168, K.169
15 PLIP interactions:8 interactions with chain M, 7 interactions with chain N,- Hydrophobic interactions: M:L.24, M:I.27, M:M.31, M:R.58, M:E.61, N:E.61
- Hydrogen bonds: M:Y.35, N:Y.35, N:S.168, N:S.168, N:K.169
- Water bridges: M:R.20
- Salt bridges: M:R.20, N:R.20, N:K.50
FEC.96: 23 residues within 4Å:- Chain O: R.20, L.24, I.27, H.28, M.31, Y.35, K.50, I.54, M.57, E.61, S.168
- Chain P: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168, K.169
- Ligands: SO4.93
19 PLIP interactions:10 interactions with chain P, 9 interactions with chain O,- Hydrophobic interactions: P:I.27, P:M.31, P:E.61, O:L.24, O:I.27, O:M.31, O:I.54, O:M.57, O:E.61
- Hydrogen bonds: P:S.168, P:S.168, P:K.169, O:Y.35
- Water bridges: P:T.164, P:T.164
- Salt bridges: P:R.20, P:K.50, O:R.20, O:H.28
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Macedo, S. et al., The nature of the di-iron site in the bacterioferritin fromDesulfovibrio desulfuricans. NAT.STRUCT.BIOL. (2003)
- Release Date
- 2003-04-01
- Peptides
- bacterioferritin: ABCDEFGHIJKLMNOP
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
NO
OP
P
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- homo-16-mer
- Ligands
- 32 x FE2: FE (II) ION(Non-covalent)
- 56 x SO4: SULFATE ION(Non-functional Binders)
- 8 x FEC: 1,3,5,8-TETRAMETHYL-PORPHINE-2,4,6,7-TETRAPROPIONIC ACID FERROUS COMPLEX(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Macedo, S. et al., The nature of the di-iron site in the bacterioferritin fromDesulfovibrio desulfuricans. NAT.STRUCT.BIOL. (2003)
- Release Date
- 2003-04-01
- Peptides
- bacterioferritin: ABCDEFGHIJKLMNOP
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
NO
OP
P